CoChat

Effects of N‐acetylcysteine on cytokines in non‐acetaminophen acute liver failure: potential mechanism of improvement in transplant‐free survival

Open access
Stravitz, R. Todd, Sanyal, Arun J., Reisch, Joan, Bajaj, Jasmohan S., Mirshahi, Farid, Cheng, Jenfeng, Lee, William M., The Acute Liver Failure Study Group · 2013 · Liver International
Cited by 69

The DOI matches its Crossref record; 7 of the 7 references it cites were found in a registry or an index.

Abstract

Background: N‐Acetylcysteine (NAC) improves transplant‐free survival in patients with non‐acetaminophen acute liver failure (ALF) when administered in early stages of hepatic encephalopathy. The mechanisms of this benefit are unknown. Aim: To determine whether NAC improves transplant‐free survival in ALF by ameliorating the surge of pro‐inflammatory cytokines. Methods: Serum samples were obtained from 78 participants of the randomized, ALF Study Group NAC Trial with grade 1 or 2 hepatic encephalopathy on randomization. Concentrations of ten cytokines, chosen to represent a wide array of inflammatory responses, were determined by multiplex enzyme‐linked immunosorbent assay ELISA. Results: In univariate analysis, predictors of transplant‐free survival included NAC administration (P = 0.012), admission bilirubin (P = 0.003), international normalized ratio INR (P = 0.0002), grade 1 vs. grade 2 encephalopathy (P = 0.006) and lower admission interleukin (IL)‐17 concentrations (P = 0.011). IL‐17 levels were higher in patients with grade 2 vs. grade 1 encephalopathy on randomization (P = 0.007) and in those who progressed to grade 3 or grade 4 encephalopathy over the following 7 days (P ≤ 0.01). Stepwise multivariate logistic regression analysis identified only NAC administration and lower IL‐17 concentrations as independent predictors of transplant‐free survival. In patients with detectable IL‐17 concentrations on admission, 78% of those who received NAC vs. 44% of those who received placebo had undetectable levels by day 3–5 (P = 0.042), and the mean decrease in IL‐17 concentrations between admission and late samples was significantly greater in patients who received NAC vs. placebo (P = 0.045). Conclusions: N‐acetylcysteine (NAC) may improve transplant‐free survival in patients with non‐acetaminophen ALF by ameliorating the production of IL‐17, which is associated with progression of hepatic encephalopathy and poor outcome.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1111/liv.12214

Cites

7 of 7 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 7 references

Cited by

See all 69

Metadata

Authors
Stravitz, R. T., Sanyal, A. J., Reisch, J., Bajaj, J. S., Mirshahi, F., Cheng, J., Lee, W. M., & The Acute Liver Failure Study Group
Venue
Liver International
Publisher
Wiley
Published
2013-06-19
Volume
33
Issue
9
Pages
1324-1331
ISSN
  • 0106-9543 (ISSN-L)
  • 1478-3223
  • 1478-3231
OpenAlex
W2117774146
Cited by
69
References
7
FWCI
2.57
Type
journal article
Language
en
Open access
green

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Effects of N‐acetylcysteine on cytokines in non‐acetaminophen acute liver failure: potential mechanism of improvement in transplant‐free survival. https://app.cochat.ai/papers/10.1111/liv.12214
The paper
Stravitz, R. T., Sanyal, A. J., Reisch, J., Bajaj, J. S., Mirshahi, F., Cheng, J., Lee, W. M., & The Acute Liver Failure Study Group. (2013). Effects of N‐acetylcysteine on cytokines in non‐acetaminophen acute liver failure: potential mechanism of improvement in transplant‐free survival. Liver International. https://doi.org/10.1111/liv.12214

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.